Company: GEHC
Filing Date: 2025-04-10
Form Type: DEF 14A
Source: 0001628280-25-017240
Chunk: 40

Company: GE HealthCare Technologies Inc.
Filing Date: 2025-04-10
Form: DEF 14A
Chunk 40
---
  |
| Boston Scientific Corporation |     | Medtronic plc                    |     | Quest Diagnostics Incorporated |

#### Compensation Decisions and Outcomes
This section provides an overview of our 2024 compensation plans, including how the Company performed against the goals established for 2024 under the One GE HealthCare Annual Bonus Plan (the “Bonus Plan”) and the GE HealthCare Technologies Inc. 2023 Long-Term Incentive Plan (the “LTI Program”). See “Compensation Actions for 2024” beginning on page 48for details about 2024 compensation for each of our NEOs.

#### Base Salaries
Base salaries are designed to provide a competitive fixed level of pay to attract and retain top talent. In determining base salaries for our NEOs, the Compensation Committee considers several factors, including individual roles, responsibilities, performance, impact, and capabilities, as well as market-competitive benchmarking data provided by the Compensation Committee’s independent consultant. For 2024, taking these considerations into account, the Compensation Committee

#### GE HEALTHCARE 2025 PROXY STATEMENT41

#### Compensation
approved a base salary increase for Mr. Arduini from $1,250,000 to $1,300,000, effective April 1, 2024, and Mr. Rott from $562,640 to $595,100 (1) , effective April 1, 2024 when he was serving as President and CEO of our Ultrasound segment. Additionally, in connection with his promotion to President and CEO of our Imaging segment, the Compensation Committee approved an increase from $595,100 to $681,660 (1) , effective July 1, 2024. Mr. Rott’s promotional increase was intended to align his annual target pay with competitive levels for his new role with expanded responsibilities overseeing the Company’s largest segment. No other changes were made to our NEOs’ base salaries for 2024.

(1) Mr. Rott’s base salary was paid in Euros and converted for purposes of this disclosure at an exchange rate of $1.0820 per €1.00, the 2024 average noon buying rate certified for customs purposes by the U.S. Federal Reserve Bank of New York set forth in the H.10 statistical release of the Federal Reserve Board.

#### Annual Bonus Plan
For 2024, we provided annual cash incentive opportunities to our executives, including our NEOs, under the Bonus Plan. The performance metrics and targets for awards under the